Individualising heart failure patients to beta-blocker therapy.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D002227:Carbazoles / Q000008:administration & dosage*; D000077261:Carvedilol; D000075202:Contraindications; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011379:Prognosis; D011412:Propanolamines / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D013019:South Africa; D015996:Survival Rate; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000401:mortality
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol